| Section Name |
Section Number |
Date Completed |
| General Information |
Section 1 |
|
| Introduction |
1-10 |
May 2010 |
| Prevention and Control of Communicable Diseases |
1-20 |
May 2010 |
| Roles of the Stakeholder |
1-30 |
May 2010 |
| The Chain of Infection |
1-40 |
May 2010 |
| |
|
|
| Respiratory and Direct Contact |
Section 2 |
|
| Introduction and General Considerations |
2-10 |
Oct 2010 |
| Diphtheria |
2-30 |
Oct 2010 |
| Group A Streptococcal Disease (invasive) |
2-40 |
Mar 2011 |
| Haemophilus influenzae |
2-50 |
Nov 2011 |
| Influenza |
2-60 |
Aug 2011 |
| Legionellosis |
2-70 |
Feb 2011 |
| Leprosy (Hansen's Disease) |
2-80 |
Feb 2011 |
| Measles |
2-90 |
Mar 2011 |
| Mumps |
2-110 |
Oct 2011 |
| Neonatal Group B Streptococcus |
2-120 |
Aug 2011 |
| Pertussis |
2-140 |
Aug 2011 |
| Pneumococcal Disease (invasive) |
2-150 |
Feb 2011 |
| Rubella |
2-160 |
Aug 2011 |
| Congenital Rubella Syndrome/Infection (CRS/CRI) |
2-165 |
Aug 2011 |
| Severe Respiratory Illness (SRI) |
2-170 |
Oct 2011 |
| Varicella (Chickenpox) |
2-210 |
Feb 2011 |
| |
|
|
| Enteric |
Section 3 |
|
| Campylobacteriosis |
3-60 |
Mar 2012 |
| Cryptosporidiosis |
3-80 |
Mar 2012 |
| Listeriosis |
3-130 |
Mar 2012 |
| Shigellosis |
3-180 |
Aug 2011 |
| Trichinosis |
3-190 |
Mar 2012 |
| Yersiniosis |
3-210 |
Mar 2012 |
| |
|
|
| Vector-Borne and Zoonotic Diseases |
Section 4 |
|
| Rabies |
4-110 |
Apr 2012 |
| |
|
|
| Sexually Transmitted Infections |
Section 5 |
|
| Introduction and General Considerations |
5-10 |
July 2010 |
| Chlamydia |
5-20 |
Jan 2012 |
| Gonococcal Infections |
5-30 |
Jan 2012 |
| Lymphogranuloma Venereum (LGV) |
5-60 |
July 2010 |
| Syphilis |
5-70 |
Jan 2011 |
| |
|
|
| Blood and Body Fluid Pathogens |
Section 6 |
|
| |
|
|
| Other |
Section 7 |
|
| Head Lice |
7-20 |
Nov 2010 |
| |
|
|
| Antibiotic Resistant Organisms/Antibiotic Associated Organisms (ARO/AAO) |
Section 8 |
|
| |
|
|
| Outbreaks |
Section 9 |
|
Outbreaks in LTC and Integrated Facilities
Generic Protocols
Generic Respiratory Protocol
Generic Enteric Protocol |
9-30
9-40
9-50 |
June 2010
June 2010
June 2010 |
|
Antiviral Use for Influenza Outbreaks in Special Care Homes
|
9-60 |
Dec 2011 |
| Appendixes |
|
|
| Reporting and Follow-up Timelines |
Appendix A |
Oct 2011 |
| Publicly Funded Medications for Chemoprophylaxis/Treatment |
Appendix D |
Sep 2011 |
| Contact Information for RHAs, FNIH and NITHA |
Appendix E |
Oct 2010 |
| Notification to Canadian Blood Services |
Appendix K |
Oct 2011 |
| |
|
|
| Selected Attachments in Word Version (Templates/Forms) |
| |
|
|
